Diabetes and weight loss drugs shown to reduce alcohol-related hospitalizations, study finds

Ozempic, Wegovy and different GLP-1 drugs person been shown to curb intoxicant effects, a caller survey suggests.

Glucagon-like peptide-1 receptor (GLP-1) agonists — which incorporate either semaglutide oregon liraglutide — are prescribed to dainty type 2 diabetes and obesity, but erstwhile studies person shown that radical study decreased intoxicant depletion erstwhile taking them.

In a caller survey by the University of Eastern Finland and Karolinska Institutet successful Sweden, researchers recovered that radical with intoxicant usage upset (AUD) were little apt to beryllium hospitalized for intoxicant oregon substance abuse-related conditions.

DRINKING ALCOHOL IS LINKED TO SIX TYPES OF CANCER, EXPERTS SAY

The researchers analyzed decades of information from 228,000 radical successful Sweden who had AUD, ranging successful property from 16 to 64, according to a property release.

Studies person shown that radical study decreased intoxicant depletion erstwhile taking glucagon-like peptide-1 receptor (GLP-1) agonists. (iStock)

For participants who had AUD, obesity and benignant 2 diabetes, the usage of GLP-1 medications was linked to "substantially decreased hazard of hospitalization owed to AUD," the researchers wrote.

Patients taking semaglutide (such arsenic Ozempic and Wegovy) showed a 36% little risk, and those taking liraglutide (Victoza) had a 28% little risk.

DRINKING ALCOHOL WEEKLY COULD BE CONNECTED TO 61 DIFFERENT DISEASES, STUDY FINDS

The GLP-1 drugs were shown to beryllium adjacent much effectual than naltrexone, which is regarded arsenic the champion cause for alcohol usage disorder.

"Our survey suggests that too obesity and diabetes, GLP-1-agonists whitethorn besides assistance successful the attraction of intoxicant and substance usage disorders; however, these findings request to beryllium further validated successful randomized controlled trials," pb survey writer Markku Lähteenvuo, docent of forensic psychiatry astatine the University of Eastern Finland and the Niuvanniemi Hospital, said successful the release.

For participants who had intoxicant usage disorder, obesity and benignant 2 diabetes, the usage of GLP-1 medications was linked to "substantially decreased hazard of hospitalization owed to AUD," the researchers wrote. (iStock)

This isn’t the archetypal survey to nexus GLP-1s to reduced intoxicant intake, according to Dr. Sue Decotiis, MD, a weight-loss doc successful New York City.

CLICK HERE TO GET THE FOX NEWS APP

"There person been galore studies that amusement GLP-1 mitigate the tendency to devour alcohol," Decotiis, who was not progressive successful the Swedish study, told Fox News Digital.

"Over 50% of my patients connected semaglutide and tirzepatide person remarkably little tendency to portion alcohol."

OZEMPIC COULD HELP REDUCE ALZHEIMER’S RISK FOR SOME, STUDY SUGGESTS: ‘SHIFTING THE PARADIGM’

Decotiis besides mentioned a caller weight-loss drug — Retatrutide, made by Eli Lilly — that is said to beryllium adjacent much effectual against intoxicant addiction. 

"All successful all, these drugs person shown clip and clip again that they heighten overall, long-term health passim the full body," she said.

Patients taking semaglutide (such arsenic Ozempic and Wegovy) showed a 36% little hazard of alcohol-related hospitalization, and those taking liraglutide (Victoza) had a 28% little risk. (iStock)

Approximately 28.9 cardinal radical 12 and older had AUD successful the past year, according to the 2023 National Survey connected Drug Use and Health.

Novo Nordisk, shaper of Ozempic and Wegovy, provided the beneath connection to Fox News Digital.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

"Novo Nordisk welcomes autarkic probe investigating the safety, efficacy and objective inferior of our products. However, nary of our semaglutide-containing products are indicated for the attraction of addiction-related illnesses."

Approximately 28.9 cardinal radical 12 and older had intoxicant usage upset successful the past year, according to the 2023 National Survey connected Drug Use and Health. (iStock)

"Importantly, our clinical studies person not been designed to measure the effectiveness of semaglutide connected intoxicant usage upset and baccy usage upset oregon different addiction-related illnesses. We enactment our products being prescribed to patients who conscionable the indicated criteria and lone beforehand the FDA-approved indications of our medicines for due patients."

For much Health articles, visit www.foxnews.com/health

Fox News Digital reached retired to the survey researchers and besides to Eli Lilly, shaper of Retatrutide, requesting comment.